Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMETISA (Instituto Médico Tinerfeño) is a public healthcare company based in Tenerife, Spain, primarily owned by the Cabildo de Tenerife. Founded in 1998, the company specializes in advanced diagnostic imaging and specialized medical treatments, notably operating high-field magnetic resonance imaging (MRI) systems and hyperbaric chambers. Beyond its clinical services, IMETISA actively participates in medical research and academic collaborations, particularly with the University of La Laguna, focusing on areas such as neuroimaging, metabolic disorders, and biomedical engineering. The institution serves as a critical hub for both public health diagnostics and translational research in the Canary Islands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMETISA.